You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 9, 2026
Sale
Calculated transaction value
$491.54K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 8, 2026
Public filing date
Oct 9, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$532.78
Oct 8, 2026
First close after public filing
$550.1
Oct 12, 2026
30-day return after filing
+5.88%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 920 shares @ $534.28
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000160
Filing cohort
Transactions in this filing
Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$6.19M
Buys / sales
0 / 16
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $257.02K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $442.16K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $105.5K |
| United Therapeutics Corp UTHR | Exercise | Oct 8, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $588.68K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $403.95K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $144.03K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $105.73K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $563.47K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $319.24K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $426.69K |
| United Therapeutics Corp UTHR Current | Sale | Oct 8, 2026 | $491.54K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $546.13K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $325.85K |
| United Therapeutics Corp UTHR | Sale | Oct 8, 2026 | $229.18K |